Clinitech Laboratory bulk deals, insider trading and stake changes
BSE: 544220Healthcare ServicesSmall Cap
Clinitech Laboratory Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2024
Last close ₹30.85down ₹1.15 (3.59%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹32.00.
28 Oct: open ₹30.85, high ₹30.85, low ₹30.85
52-week range of traded prices to 28 Oct 2026
₹28.55Low, 29 Jan 2026₹47.15High, 9 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7.04 Cr4,713th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.85
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 4.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.06
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,200
Clinitech Laboratory's insiders have 12 trade disclosures on record, the latest on 30 Mar 2026. Over the 12 months to 29 Oct 2026 its promoter group made 9 purchases on the market, a net purchase of 42,000 shares.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Clinitech Laboratory promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group9 purchases, 0 sales₹0.14 Cr1 more with no value filedNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.14 Crof the trades with a value
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Clinitech Laboratory insider trading
Mar 2026
- Mr. Jagdish Umakant Nayak₹0.03 Cr9,600 sharesBought · Promoter and Director · 30 Mar 2026 · stake 31.65% before, 32.08% after
- Mr. Siddhesh Anant Nayak₹46,8001,200 sharesBought · Promoter Group · 27 Mar 2026 · stake 2.90% before, 3.00% after
- Mr. Jagdish Umakant Nayak₹42,0001,200 sharesBought · Promoter and Director · 25 Mar 2026 · disclosed 27 Mar · stake 31.60% before, 31.65% after
- Mr. Siddhesh Anant Nayak₹86,9882,400 sharesBought · Promoter Group · 24 Mar 2026 · disclosed 25 Mar · stake 2.80% before, 2.90% after
- JAGDISH UMAKANT NAYAK₹0.02 Cr4,800 sharesBought · Promoter and Director · 19 Mar 2026 · disclosed 20 Mar · stake 31.39% before, 31.60% after
- JAGDISH UMAKANT NAYAK4,800sharesBought · Promoter and Director · 17 Mar 2026 · disclosed 18 Mar · stake 31.18% before, 31.39% after
- JAGDISH UMAKANT NAYAK₹0.02 Cr6,000 sharesBought · Promoter and Director · 12 Mar 2026 · disclosed 13 Mar · stake 30.92% before, 31.18% after
- JAGDISH UMAKANT NAYAK₹0.03 Cr8,400 sharesBought · Promoter and Director · 11 Mar 2026 · disclosed 12 Mar · stake 30.55% before, 30.92% after
- JAGDISH UMAKANT NAYAK₹0.02 Cr3,600 sharesBought · Promoter and Director · 10 Mar 2026 · stake 30.39% before, 30.55% after
Sep 2025
- JAGDISH UMAKANT NAYAK₹0.04 Cr8,400 sharesBought · Promoter and Director · 26 Sep 2025 · disclosed 27 Sep · stake 30.03% before, 30.39% after
Aug 2025
- SIDDHESH ANANT NAYAK₹0.01 Cr2,400 sharesBought · Promoter Group · 18 Aug 2025 · disclosed 19 Aug · stake 2.43% before, 2.54% after
- JAGDISH UMAKANT NAYAK₹0.04 Cr8,400 sharesBought · Promoter and Director · 18 Aug 2025 · disclosed 19 Aug · stake 29.55% before, 29.92% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Clinitech Laboratory stake sales and purchases
All 12 disclosures on record.
Mar 2026
- AcquiredJagdish Nayak & PACs · promoter0.42% of the company9,600 sharesholds 64.62% after30 Mar 2026 · filed under the 2% rule · Market
- AcquiredSiddhesh Nayak & PACs · promoter0.05% of the company1,200 sharesholds 64.20% after27 Mar 2026 · filed under the 2% rule · Market
- AcquiredJagdish Umakant Nayak & PACs · promoter0.05% of the company1,200 sharesholds 64.15% after25 Mar 2026 · filed under the 2% rule · Market
- AcquiredSiddhesh Anant Nayak & PACs · promoter0.11% of the company2,400 sharesholds 64.10% after24 Mar 2026 · filed under the 2% rule · Market
- AcquiredJagdish Umakant Nayak & PACs · promoter0.21% of the company4,800 sharesholds 63.99% after20 Mar 2026 · filed under the 2% rule · Market
- AcquiredJagdish Umakant Nayak & PACs · promoter0.21% of the company4,800 sharesholds 63.78% after18 Mar 2026 · filed under the 2% rule · Market
- AcquiredJagdish Umakant Nayak · promoter0.26% of the company6,000 sharesholds 31.18% after13 Mar 2026 · filed under the 2% rule · Market
- AcquiredJagdish Umakant Nayak · promoter0.37% of the company8,400 sharesholds 30.92% after11 Mar 2026 · filed under the 2% rule · Market
- AcquiredJagdish Umakant Nayak · promoter0.16% of the company3,600 sharesholds 30.55% after10 Mar 2026 · filed under the 2% rule · Market
Sep 2025
- AcquiredJagdish Umakant Nayak · promoter0.37% of the company8,400 sharesholds 30.39% after26 Sep 2025 · filed under the 2% rule · Market
Aug 2025
- AcquiredSiddhesh Anant Nayak · promoter0.11% of the company2,400 sharesholds 2.54% after18 Aug 2025 · filed under the 2% rule · Market
- AcquiredJagdish Umakant Nayak · promoter0.37% of the company8,400 sharesholds 29.92% after18 Aug 2025 · filed under the 2% rule · Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Clinitech Laboratory bulk deals
Last 12 months, since 30 Oct 2025: 7 bulk deals, ₹0.21 Cr bought and ₹0.19 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 16 Apr 20261 firm · ₹0.06 Cr bought · ₹0 soldNet bought ₹0.06 Cr
- BoughtVORTON OPPORTUNITIES FUNDBought 14,400 at ₹44.520.63% of the company₹0.06 Cr
Monday 23 Mar 20263 firms · ₹0.04 Cr bought · ₹0.10 Cr soldNet sold ₹0.06 Cr
- SoldMUKESH KESHUBHAI THUMARSold 16,800 at ₹32.950.74% of the company₹0.06 Cr
- SoldBINABEN BIPINKUMAR MEHTASold 12,000 at ₹33.200.53% of the company₹0.04 Cr
- BoughtSIDDHARTH BIPINBHAI MEHTABought 12,000 at ₹33.200.53% of the company₹0.04 Cr
Tuesday 17 Mar 20261 firm · ₹0 bought · ₹0.06 Cr soldNet sold ₹0.06 Cr
- SoldSANJAY HARSHADRAI MEHTASold 18,000 at ₹33.340.79% of the company₹0.06 Cr
Thursday 29 Jan 20262 firms · ₹0.05 Cr bought · ₹0.04 Cr soldNet bought ₹0.01 Cr
- BoughtSANJAY HARSHADRAI MEHTABought 15,600 at ₹32.320.68% of the company₹0.05 Cr
- SoldRAHUL R MAHAJANSold 12,000 at ₹29.540.53% of the company₹0.04 Cr
Monday 17 Nov 20251 firm · ₹0.05 Cr bought · ₹0 soldNet bought ₹0.05 Cr
- BoughtBINABEN BIPINKUMAR MEHTABought 13,200 at ₹40.150.58% of the company₹0.05 Cr
Tuesday 19 Aug 20252 firms · ₹0.09 Cr bought · ₹0.10 Cr soldNet sold ₹0.01 Cr
- SoldKRIPANANDA CHIDAMBARAMSold 15,600 at ₹52.970.68% of the company₹0.08 Cr
- Both waysBONANZA PORTFOLIO LIMITEDBought 16,800 at ₹52.92Sold 3,600 at ₹52.970.74% of the companyNet +13,200 shares₹0.09 Cr bought
Tuesday 22 Jul 20252 firms · ₹0.18 Cr bought · ₹0.18 Cr soldNet nil
- BoughtKRISHA VISHAL TALREJABought 56,400 at ₹32.152.47% of the company₹0.18 Cr
- SoldVISHAL ASHOK TALREJASold 56,400 at ₹32.152.47% of the company₹0.18 Cr
Monday 10 Feb 20251 firm · ₹0 bought · ₹0.17 Cr soldNet sold ₹0.17 Cr
- SoldSANJAY HARSHADRAI MEHTASold 21,600 at ₹78.430.95% of the company₹0.17 Cr
Friday 13 Sep 20242 firms · ₹0.12 Cr bought · ₹0.12 Cr soldNet nil
- BoughtBINABEN BIPINKUMAR MEHTABought 14,400 at ₹80.100.63% of the company₹0.12 Cr
- SoldBIPINKUMAR RAMESHCHANDRA MEHTASold 14,400 at ₹80.100.63% of the company₹0.12 Cr
Friday 16 Aug 20241 firm · ₹0 bought · ₹0.13 Cr soldNet sold ₹0.13 Cr
- SoldVINAYAK GOPALKRISHNA KUDVASold 14,400 at ₹88.030.63% of the company₹0.13 Cr
Wednesday 14 Aug 20241 firm · ₹0 bought · ₹0.13 Cr soldNet sold ₹0.13 Cr
- SoldMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSold 14,400 at ₹88.420.63% of the company₹0.13 Cr
Tuesday 13 Aug 20241 firm · ₹0 bought · ₹0.13 Cr soldNet sold ₹0.13 Cr
- SoldMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSold 14,400 at ₹93.070.63% of the company₹0.13 Cr
Friday 9 Aug 20241 firm · ₹0.27 Cr bought · ₹0 soldNet bought ₹0.27 Cr
- BoughtMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 30,000 at ₹88.801.31% of the company₹0.27 Cr
Friday 2 Aug 20242 firms · ₹0.26 Cr bought · ₹0.14 Cr soldNet bought ₹0.12 Cr
- BoughtRAHUL R MAHAJAN .Bought 22,800 at ₹114.72₹0.26 Cr
- SoldVIRTUOUS CAPITAL LIMITEDSold 12,000 at ₹114.72₹0.14 Cr
Thursday 1 Aug 20245 firms · ₹0.84 Cr bought · ₹0.36 Cr soldNet bought ₹0.49 Cr
- BoughtSANJAY HARSHADRAI MEHTABought 32,400 at ₹119.51₹0.39 Cr
- Both waysSVCM SECURITIES PRIVATE LIMITEDBought 1,200 at ₹113.95Sold 31,200 at ₹114.40Net −30,000 shares₹0.01 Cr bought
- BoughtBIPINKUMAR RAMESHCHANDRA MEHTABought 14,400 at ₹115.00₹0.17 Cr
- BoughtMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 12,000 at ₹115.00₹0.14 Cr
- BoughtSHARAD BEHARILAL HARLALKABought 12,000 at ₹115.00₹0.14 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 25 deals on record since listing on 1 Aug 2024.